Patients should not use Tesamorelin or growth hormone-related peptides without a review of labs, medical history, medications, glucose markers, cancer history, and body composition goals
When considering the use of melatonin and folinic acid for individuals with autism, it is essential to consult with healthcare professionals to determine the appropriate dosage and ensure safe and effective supplementation
In a Phase 1 clinical trial, AMG133 demonstrated significant dose-dependent weight loss effects, achieving up to a 14.5% reduction in body weight compared to a 1.5% reduction for the placebo group on day 85
Water fills space in the stomach, supports digestion, and can prevent mistaking thirst for hunger when you feel still hungry on tirzepatide
A patient starting at 300 pounds may see faster initial losses than someone at 200 pounds, partly because larger caloric deficits are easier to achieve at higher baseline weights